2023-03-30T16:58:22+08:00 weekly 1.0 https://otq.prisysbiotech.com/ 2024-11-08T17:33:35+08:00 weekly 0.9 https://otq.prisysbiotech.com/metabolic-syndromes-research 2024-11-08T17:33:43+08:00 weekly 0.9 https://otq.prisysbiotech.com/respiratory-disease-research 2024-11-08T17:33:46+08:00 weekly 0.9 https://otq.prisysbiotech.com/inflammation-immunology-disorders 2024-11-08T17:33:29+08:00 weekly 0.9 https://otq.prisysbiotech.com/hematological-disease-research 2024-11-08T17:33:35+08:00 weekly 0.9 https://otq.prisysbiotech.com/cns-disorders-behavior-analysis 2024-11-08T18:45:28+08:00 weekly 0.9 https://otq.prisysbiotech.com/ophthalmic-disease-research 2023-04-01T16:23:36+08:00 weekly 0.9 https://otq.prisysbiotech.com/co-develop 2024-11-08T17:33:31+08:00 weekly 0.9 https://otq.prisysbiotech.com/animal-welfare 2024-11-08T17:33:28+08:00 weekly 0.9 https://otq.prisysbiotech.com/translational-research-center 2026-08-08T06:41:25+08:00 weekly 0.9 https://otq.prisysbiotech.com/download 2024-09-29T14:23:03+08:00 weekly 0.9 https://otq.prisysbiotech.com/fibrosis 2024-09-29T14:45:25+08:00 weekly 0.9 https://otq.prisysbiotech.com/nephrology 2024-11-08T17:33:33+08:00 weekly 0.9 https://otq.prisysbiotech.com/about-us 2024-11-08T17:33:32+08:00 weekly 0.9 https://otq.prisysbiotech.com/contact-us 2023-04-01T16:23:54+08:00 weekly 0.9 https://otq.prisysbiotech.com/newslist-1 2024-11-08T17:33:36+08:00 weekly 0.9 https://otq.prisysbiotech.com/products 2023-04-01T14:32:59+08:00 weekly 1.0 https://otq.prisysbiotech.com/nhp-pharmacology/ 2023-04-01T14:33:00+08:00 weekly 0.9 https://otq.prisysbiotech.com/pk-pd-adme/ 2023-04-01T14:33:00+08:00 weekly 0.9 https://otq.prisysbiotech.com/safety-evaluation/ 2023-04-01T14:33:01+08:00 weekly 0.9 https://otq.prisysbiotech.com/translation-research/ 2023-04-01T14:33:05+08:00 weekly 0.9 https://otq.prisysbiotech.com/biosafety-research/ 2024-04-09T22:38:30+08:00 weekly 0.9 https://otq.prisysbiotech.com/clearpoint/ 2023-03-30T05:20:23+08:00 weekly 0.8 https://otq.prisysbiotech.com/nhp-pharmacology/non-human-primate.html 2026-08-15T09:52:15+08:00 weekly 0.8 https://otq.prisysbiotech.com/nhp-pharmacology/what-is-a-nhp-study.html 2024-11-08T17:25:40+08:00 weekly 0.8 https://otq.prisysbiotech.com/nhp-pharmacology/the-nhp-pharmacology-of-prisys.html 2024-11-08T19:11:03+08:00 weekly 0.8 https://otq.prisysbiotech.com/pk-pd-adme/toxicokinetics.html 2024-11-08T18:44:06+08:00 weekly 0.8 https://otq.prisysbiotech.com/safety-evaluation/dose-range-finding-test.html 2023-04-01T16:22:02+08:00 weekly 0.8 https://otq.prisysbiotech.com/safety-evaluation/single-dose-repeated-dose-toxicity-testing.html 2024-11-08T17:27:27+08:00 weekly 0.8 https://otq.prisysbiotech.com/pk-pd-adme/pharmacokinetics.html 2023-04-01T16:22:15+08:00 weekly 0.8 https://otq.prisysbiotech.com/safety-evaluation/toxicology.html 2023-04-01T16:22:15+08:00 weekly 0.8 https://otq.prisysbiotech.com/pk-pd-adme/adme.html 2024-11-08T17:27:24+08:00 weekly 0.8 https://otq.prisysbiotech.com/pk-pd-adme/pharmacodynamics.html 2024-11-08T17:27:14+08:00 weekly 0.8 https://otq.prisysbiotech.com/nhp-pharmacology/nhp-monkey-disease-models.html 2026-08-15T09:57:50+08:00 weekly 0.8 https://otq.prisysbiotech.com/safety-evaluation/immunotoxicity.html 2023-04-01T16:22:19+08:00 weekly 0.8 https://otq.prisysbiotech.com/safety-evaluation/new-and-modified-applications.html 2023-04-01T16:22:18+08:00 weekly 0.8 https://otq.prisysbiotech.com/translation-research/translational-studies.html 2024-11-08T18:44:15+08:00 weekly 0.8 https://otq.prisysbiotech.com/biosafety-research/biosafetyresearch.html 2024-11-08T17:27:15+08:00 weekly 0.8 https://otq.prisysbiotech.com/translation-research/nhpresources.html 2024-11-08T17:29:52+08:00 weekly 0.8 https://otq.prisysbiotech.com/nhp-pharmacology/nhp-asthma-atopic-dermatitis-model.html 2024-11-08T17:29:50+08:00 weekly 0.8 https://otq.prisysbiotech.com/nhp-pharmacology/nhp-lung-fibrosis-model.html 2024-11-08T17:29:56+08:00 weekly 0.8 https://otq.prisysbiotech.com/nhp-pharmacology/nhp-non-alcoholic-steatohepatitis-nash-model.html 2023-04-01T16:22:29+08:00 weekly 0.8 https://otq.prisysbiotech.com/nhp-pharmacology/nhp-chronic-obstructive-pulmonary-disease.html 2023-04-01T16:22:34+08:00 weekly 0.8 https://otq.prisysbiotech.com/nhp-pharmacology/non-human-primate-model-renal-ischemia.html 2024-11-08T17:29:52+08:00 weekly 0.8 https://otq.prisysbiotech.com/nhp-pharmacology/hemophilia-a-nonhuman-primates-disease-model.html 2023-04-01T16:22:41+08:00 weekly 0.8 https://otq.prisysbiotech.com/nhp-pharmacology/coagulation-hemostasis-nonhuman-primates.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://otq.prisysbiotech.com/nhp-pharmacology/heart-failure-nonhuman-primates-disease-model.html 2023-04-01T16:22:42+08:00 weekly 0.8 https://otq.prisysbiotech.com/nhp-pharmacology/embolism-nonhuman-primates-disease-model.html 2023-04-01T16:22:43+08:00 weekly 0.8 https://otq.prisysbiotech.com/nhp-pharmacology/myopia-hyperopia-nhp-model.html 2023-04-01T16:22:47+08:00 weekly 0.8 https://otq.prisysbiotech.com/nhp-pharmacology/uveitis-nonhuman-primates-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://otq.prisysbiotech.com/nhp-pharmacology/amd-nonhuman-primates-disease-model.html 2023-04-01T16:22:49+08:00 weekly 0.8 https://otq.prisysbiotech.com/nhp-pharmacology/glaucoma-nonhuman-primates-disease-model.html 2024-11-08T17:29:58+08:00 weekly 0.8 https://otq.prisysbiotech.com/nhp-pharmacology/psoriasis-nonhuman-primates-disease-model.html 2024-11-08T17:29:56+08:00 weekly 0.8 https://otq.prisysbiotech.com/nhp-pharmacology/delayed-type-hypersensitivity-dth-nonhuman.html 2023-04-01T16:22:51+08:00 weekly 0.8 https://otq.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-nhp-disease-model.html 2024-11-08T17:29:58+08:00 weekly 0.8 https://otq.prisysbiotech.com/nhp-pharmacology/tdar-nonhuman-primates-disease-model.html 2024-11-08T17:30:03+08:00 weekly 0.8 https://otq.prisysbiotech.com/nhp-pharmacology/rheumatoid-arthritis-nhp-model.html 2024-11-08T17:30:09+08:00 weekly 0.8 https://otq.prisysbiotech.com/nhp-pharmacology/epilepsy-nhp-model.html 2024-11-09T05:03:39+08:00 weekly 0.8 https://otq.prisysbiotech.com/nhp-pharmacology/mcao-nhp-model.html 2023-04-01T16:22:55+08:00 weekly 0.8 https://otq.prisysbiotech.com/nhp-pharmacology/multiple-sclerosis-nhp-model.html 2024-11-08T17:30:08+08:00 weekly 0.8 https://otq.prisysbiotech.com/nhp-pharmacology/neuropathic-pain-nhp-model.html 2024-11-08T17:22:21+08:00 weekly 0.8 https://otq.prisysbiotech.com/clearpoint/clearpoint-navigation-for-cns-research.html 2024-11-09T07:07:48+08:00 weekly 0.8 https://otq.prisysbiotech.com/translation-research/ai-based-nhp-behavior-analysis-system.html 2024-11-08T17:22:14+08:00 weekly 0.8 https://otq.prisysbiotech.com/nhp-pharmacology/parkinson-s-disease-model.html 2024-11-08T17:22:45+08:00 weekly 0.8 https://otq.prisysbiotech.com/translation-research/clinical-imaging.html 2024-09-28T03:57:19+08:00 weekly 0.8 https://otq.prisysbiotech.com/nhp-pharmacology/a-v-shunt-model.html 2024-09-28T03:57:16+08:00 weekly 0.8 https://otq.prisysbiotech.com/nhp-pharmacology/renal-fibrosis-model.html 2024-09-27T22:02:55+08:00 weekly 0.8 https://otq.prisysbiotech.com/nhp-pharmacology/immunosuppression-model.html 2024-09-28T03:57:20+08:00 weekly 0.8 https://otq.prisysbiotech.com/nhp-pharmacology/hyperlipoidemia-model.html 2024-11-08T17:23:40+08:00 weekly 0.8 https://otq.prisysbiotech.com/nhp-pharmacology/type-2-diabetes-mellitus-model.html 2024-09-28T03:57:31+08:00 weekly 0.8 https://otq.prisysbiotech.com/nhp-pharmacology/endometriosis-model.html 2024-09-28T03:57:14+08:00 weekly 0.8 https://otq.prisysbiotech.com/nhp-pharmacology/type-1-diabetes-mellitus-model.html 2024-12-08T16:04:56+08:00 weekly 0.8 https://otq.prisysbiotech.com/clearpoint/nhp-neuroscience.html 2024-12-08T16:05:08+08:00 weekly 0.8 https://otq.prisysbiotech.com/clearpoint/convection-enhanced-delivery-ced-technology.html 2025-03-31T02:14:34+08:00 weekly 0.8 https://otq.prisysbiotech.com/nhp-pharmacology/pruritus-nhp-model.html 2025-03-31T02:34:58+08:00 weekly 0.8 https://otq.prisysbiotech.com/nhp-pharmacology/atopic-dermatitis-nhp-model.html 2025-07-17T23:16:10+08:00 weekly 0.8 https://otq.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-disease-ibd-nhp-model.html 2025-07-17T23:16:16+08:00 weekly 0.8 https://otq.prisysbiotech.com/translation-research/targeted-organ-drug-delivery-platform-in-nhp.html 2025-09-06T03:30:58+08:00 weekly 0.8 https://otq.prisysbiotech.com/nhp-pharmacology/aav-synuclein-overexpression-nhp-model.html 2025-09-15T07:08:44+08:00 weekly 0.8 https://otq.prisysbiotech.com/nhp-pharmacology/heart-failure-nhp-model.html 2025-09-20T06:55:32+08:00 weekly 0.8 https://otq.prisysbiotech.com/nhp-pharmacology/acute-lung-inflammation-ali-nhp-model.html 2025-09-25T03:51:15+08:00 weekly 0.8 https://otq.prisysbiotech.com/pk-pd-adme/nose-to-brain-drug-delivery.html 2025-09-29T15:27:52+08:00 weekly 0.8 https://otq.prisysbiotech.com/nhp-pharmacology/acute-hemorrhagic-shock-model-nhp-model.html 2025-12-23T10:52:56+08:00 weekly 0.8 https://otq.prisysbiotech.com/nhp-pharmacology/retinitis-pigmentosa-rp-nhp-model.html 2026-01-29T15:05:17+08:00 weekly 0.8 https://otq.prisysbiotech.com/nhp-pharmacology/liver-fibrosis-model.html 2026-05-09T04:36:57+08:00 weekly 0.8 https://otq.prisysbiotech.com/translation-research/biodistribution-imaging-service.html 2026-05-09T04:38:36+08:00 weekly 0.8 https://otq.prisysbiotech.com/pk-pd-adme/nhp-intrathecal-dosing-csf-sampling.html 2026-05-09T04:38:55+08:00 weekly 0.8 https://otq.prisysbiotech.com/pk-pd-adme/nhp-intracerebral-injection-icm-services.html 2026-05-09T04:38:36+08:00 weekly 0.8 https://otq.prisysbiotech.com/translation-research/dsa-guided-interventional-platform.html 2026-05-28T11:29:55+08:00 weekly 0.8 https://otq.prisysbiotech.com/nhp-pharmacology/nhp-focal-segmental-glomerulosclerosis-fsgs.html 2026-05-28T11:32:20+08:00 weekly 0.8 https://otq.prisysbiotech.com/pk-pd-adme/nhp-intracerebroventricular-icv-injection.html 2023-04-01T14:32:55+08:00 weekly 0.9 https://otq.prisysbiotech.com/newslist-714530-1 2023-04-01T14:32:57+08:00 weekly 0.9 https://otq.prisysbiotech.com/newslist-714531-1 2024-07-30T06:41:48+08:00 weekly 0.9 https://otq.prisysbiotech.com/newslist-818823-1 2026-05-09T04:30:11+08:00 weekly 0.9 https://otq.prisysbiotech.com/newslist-17864851954902016-1 2023-04-01T16:21:48+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/meetprisys-sot2023-66148294.html 2026-09-02T00:50:14+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/do-we-need-further-studies-for-pain-assessment-66148295.html 2023-04-01T16:21:49+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/prisys-celebrating-world-wildlife-day-66148296.html 2023-04-01T16:21:47+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/the-construction-of-prisys-shanghai-nhp-r-d-ce-66148297.html 2023-04-01T16:21:54+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/prisys-sot2023-66148298.html 2026-09-02T00:50:19+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/prisys-biotech-non-human-primate-pharmacology-66148300.html 2026-09-02T00:50:03+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/gene-therapy-nhp-model-66148301.html 2026-09-02T00:50:11+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/top-10-popular-questions-related-to-gene-thera-66148302.html 2023-04-01T16:21:56+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/supporting-women-s-health-a-look-into-endomet-66148303.html 2026-09-02T00:46:28+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/dmpk-study-for-gene-therapy-66148323.html 2026-09-02T00:49:36+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/gene-therapy-toxicology-66268681.html 2023-05-05T10:53:29+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/world-parkinsons-disease-day-67240299.html 2026-09-02T00:49:28+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/unleashing-the-therapeutic-potential-67240300.html 2026-09-02T00:46:31+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/nhp-effectively-in-gene-therapy-67240301.html 2026-09-02T00:49:24+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/unlocking-the-potential-of-nonhuman-primates-67240306.html 2023-05-05T10:53:32+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/celebrating-world-day-for-laboratory-animals-67240309.html 2026-09-02T00:49:31+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/maximizing-crispr-cas9-research-efficiency-wit-67240311.html 2026-09-02T00:49:32+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/how-nonhuman-primates-can-revolutionize-sirna-67240312.html 2026-09-02T00:49:35+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/maximizing-sirna-pharmacology-efficiency-67240313.html 2026-09-02T00:49:05+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/revolutionizing-drug-discovery-nhp-68257547.html 2023-06-07T22:22:01+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/meet-prisys-biotech-at-70th-jalas-68257548.html 2026-09-02T00:41:42+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/why-you-should-care-about-non-human-primates-68257549.html 2026-09-02T00:49:11+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/gene-therapy-shines-with-new-approvals-for-rar-68257550.html 2026-09-02T00:42:17+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/an-optimal-animal-model-of-ischemic-stroke-est-68479618.html 2026-09-02T00:42:29+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/how-aav-gene-therapy-can-save-your-vision-the-69022059.html 2026-09-02T00:42:35+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/what-are-lipid-nanoparticles-for-gene-therapy-69022063.html 2026-09-10T15:41:28+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/prisys-biotech-invites-you-to-participate-in-t-69022074.html 2026-09-02T00:42:24+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/the-promising-future-of-aav-gene-therapy-in-no-69022083.html 2026-09-02T00:42:46+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/immunotoxicity-test-drug-safety-evaluation-pr-69022090.html 2026-09-02T00:42:11+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/prisys-biotech-showcases-non-human-primate-mod-69022105.html 2026-09-02T00:42:27+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/large-animal-experiment-public-service-platfor-69310245.html 2026-09-02T00:42:14+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/what-is-the-efficiency-of-rnai-69310246.html 2026-09-02T00:52:10+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/how-china-monkey-help-to-conduct-preclinical-r-69310247.html 2026-09-02T00:49:03+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/how-to-lose-weight-and-control-diabetes-with-g-69310251.html 2023-08-02T15:44:38+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/prisys-biotechnology-a-leader-in-nhp-cns-dise-69673168.html 2026-07-26T00:43:14+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/key-research-points-of-adc-drug-pk-69673169.html 2026-09-02T00:42:43+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/method-for-establishing-a-cynomolgus-monkey-mo-70999191.html 2026-09-02T00:42:29+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/0-70999192.html 2026-09-02T00:43:09+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/pharmacology-main-parameters-and-significance-70999194.html 2026-09-02T00:38:52+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/preclinical-pharmacology-evaluation-of-oncolyt-70999195.html 2026-09-02T00:42:46+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/prisys-providing-high-quality-animal-experime-70999196.html 2026-09-02T00:42:19+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/pharmacokinetics-research-strategies-and-case-70999197.html 2026-09-02T00:42:57+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-macaque-animal-mod-72324931.html 2026-09-10T15:41:28+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/prisys-biotech-invites-you-to-attend-sapa-chin-72324932.html 2026-09-02T00:42:51+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/world-alzheimer-s-day-the-challenges-and-sol-72324933.html 2026-09-10T15:41:28+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/meet-prisys-biotech-at-the-society-for-neurosc-72324934.html 2026-09-02T00:43:10+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/world-stroke-day-focus-on-ischemic-stroke-an-72324936.html 2023-11-21T16:57:08+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/exhibition-review-prisys-biotech-shines-at-t-72680470.html 2026-09-02T00:50:52+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/non-human-primates-a-brief-introduction-to-th-73012968.html 2026-09-02T00:50:39+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/how-ultrasound-guided-liver-biopsy-enhances-ma-73531642.html 2026-09-02T00:50:26+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/guidelines-for-lifetime-use-of-nonhuman-primat-73531644.html 2026-07-26T00:43:18+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/revolutionizing-cns-drug-delivery-prisys-and-74164045.html 2026-09-02T00:50:43+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/elevating-nucleic-acid-therapeutics-through-cu-74709817.html 2026-09-02T00:52:37+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/prisys-advancing-animal-experimentation-throu-74827456.html 2026-09-02T00:50:42+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/nonhuman-primate-study-newsletter-2024-q-75182781.html 2026-09-02T00:46:59+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/non-clinical-pharmacodynamics-research-an-ess-75182782.html 2026-09-02T00:50:43+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/prisys-achieves-full-accreditation-from-aaalac-76193754.html 2024-04-27T07:53:55+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/innovative-solutions-for-advancing-respiratory-77063493.html 2026-09-02T00:50:50+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/mri-guided-large-animal-central-nervous-system-77712903.html 2024-11-08T17:22:04+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/prisys-biotech-2024-q2-newsletter-77712904.html 2026-09-02T00:43:01+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/direct-delivery-of-oligonucleotide-drugs-to-th-79192531.html 2026-09-02T00:40:05+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/nhp-asthma-model-79192532.html 2026-09-02T00:43:28+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/advancing-immunology-and-inflammation-research-79192533.html 2026-09-02T00:43:05+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/intra-cerebrovascular-stroke-ich-model-prisys-79192534.html 2026-09-02T00:43:04+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/non-na-ve-nhps-in-preclinical-trials-a-cost-e-79192535.html 2026-09-02T00:43:16+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/cynomolgus-monkey-in-ophthalmic-drug-research-79419182.html 2024-11-08T17:21:40+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/revolutionizing-cns-drug-development-prisys-b-79419183.html 2026-09-02T00:43:28+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/prisys-nhp-models-immunology-inflammatio-79419184.html 2026-09-02T00:47:15+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/pk-strategies-of-pdc-79546700.html 2026-09-02T00:50:50+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/optimized-nonclinical-immunogenicity-evaluatio-79546713.html 2026-09-02T00:51:10+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/nonclinical-safety-evaluation-of-ocular-drug-d-79546715.html 2026-09-02T00:50:56+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/reducing-the-use-of-nonhuman-primates-in-noncl-79546719.html 2026-09-02T00:51:06+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/the-role-of-aav-in-gene-therapy-immune-respon-79546721.html 2026-09-02T00:44:01+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/preclinical-animal-studies-1-animal-specie-79546747.html 2026-09-02T00:43:55+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/clinical-pathology-data-interpretation-challen-79546748.html 2026-09-02T00:44:37+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/preclinical-animal-studies-2-routes-and-vo-79546749.html 2026-09-02T00:44:22+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79546750.html 2026-09-02T00:50:56+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/integrating-cns-safety-evaluation-into-79546816.html 2026-09-02T00:44:30+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79546817.html 2026-09-02T00:44:37+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/how-to-conduct-preclinical-pharmacology-toxico-79546818.html 2026-09-02T00:45:00+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/advancing-cns-and-cgt-research-prisys-biotech-79546819.html 2026-09-02T00:45:34+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/considerations-for-interpreting-clinical-patho-79546820.html 2026-09-02T00:44:53+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/non-human-primate-cerebrospinal-fluid-collecti-79546821.html 2026-09-02T00:45:59+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/how-to-evaluate-preclinical-pharmacological-ef-79546822.html 2026-09-02T00:45:20+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/reflections-on-non-clinical-pharmacology-studi-79546823.html 2026-09-02T00:45:55+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/nonclinical-study-evaluation-q-a-79546824.html 2026-09-02T00:46:14+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/insight-into-the-sensory-and-behavioral-traits-79546825.html 2026-09-02T00:51:55+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/key-points-in-designing-strategies-for-non-79546826.html 2026-09-02T00:45:53+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/application-prospects-of-gene-drugs-based-on-l-79546827.html 2026-09-02T00:46:11+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/advancing-sirna-therapeutics-overcoming-chall-79546828.html 2026-09-02T00:46:30+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/liver-toxicity-as-a-key-concern-for-sirna-drug-79546829.html 2026-09-02T00:46:17+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/revolutionizing-metabolic-disease-treatment-a-79546830.html 2026-09-02T00:46:32+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/the-significant-role-of-experimental-monkeys-i-79546831.html 2026-09-02T00:46:15+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/the-vital-role-of-experimental-monkeys-in-adva-79546832.html 2026-09-02T00:46:35+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/understanding-macaca-fascicularis-cynomolgus-79546833.html 2026-09-02T00:46:41+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/how-drugs-move-and-change-in-our-bodies-a-bri-79546834.html 2026-09-02T00:46:32+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/group-housing-guidelines-for-laboratory-monkey-79546835.html 2026-09-02T00:46:26+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/how-to-develop-new-drugs-faster-and-safer-a-g-79546836.html 2026-09-02T00:46:37+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/how-to-deliver-biologics-to-the-brain-79546837.html 2026-09-02T00:46:17+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/significance-principles-and-requirements-of-79546838.html 2026-09-02T00:46:52+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/prisys-biotechnology-novel-lipid-nanoparticle-79546839.html 2026-09-02T00:51:02+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/chinese-scientists-offers-new-strategies-to-re-79546840.html 2026-09-02T00:51:29+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/factors-to-consider-for-the-immunogenicity-of-79546841.html 2026-09-02T00:50:07+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/the-main-factors-considered-in-woe-analysis-79546842.html 2026-09-02T00:46:37+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/the-importance-of-translational-medicine-resea-79546843.html 2026-09-02T00:51:57+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79546844.html 2026-09-02T00:51:46+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/mrna-a-powerful-and-versatile-tool-for-fighti-79546845.html 2026-09-02T00:51:20+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79546846.html 2026-09-02T00:47:04+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/brief-introduction-about-biological-analysis-o-79546847.html 2026-09-02T00:51:24+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/pharmacodynamic-pd-evaluation-of-gene-therap-79546848.html 2026-09-02T00:47:07+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/mrna-based-therapies-future-and-challenges-79546854.html 2026-09-02T00:51:20+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/mrna-based-therapies-past-79546855.html 2026-09-02T00:46:59+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/mrna-based-therapies-present-79546856.html 2026-09-02T00:51:50+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/lcms-preclinical-bioanalysis-of-lnp-based-gene-79546857.html 2026-09-02T00:46:24+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/how-to-evaluate-the-safety-of-skin-products-be-79551443.html 2026-09-02T00:51:36+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/advancements-in-cns-research-ced-imri-79656466.html 2026-09-02T00:51:34+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/advanced-cns-delivery-techniques-in-cynomolgus-81160086.html 2026-09-02T00:52:11+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/cynomolgus-monkey-chronic-kidney-disease-model-81160087.html 2026-09-02T00:52:18+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/the-importance-of-preclinical-pharmacodynamics-81160088.html 2026-09-02T00:52:28+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/intranasal-administration-in-animal-studies-81160089.html 2026-09-02T00:51:52+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/convection-enhanced-delivery-81160090.html 2026-09-02T00:47:16+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/animal-models-of-human-diseases-81160091.html 2026-09-02T00:47:11+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/human-disease-animal-models-81160092.html 2026-09-02T00:47:44+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/dmpk-evaluation-of-central-nervous-system-cns-81160093.html 2026-09-02T00:52:29+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/cynomolgus-monkey-mcao-model-81160094.html 2026-09-02T00:47:34+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/rtimri-for-parkinsons-disease-81160095.html 2026-09-02T00:48:04+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/compartment-pk-model-81160097.html 2026-09-02T00:47:17+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/innovations-in-pain-evaluation-ai-driven-beha-81168510.html 2026-09-02T00:47:17+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/china-experimental-monkey-industry-81168511.html 2026-09-02T00:47:27+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/advances-in-mrna-pulmonary-delivery-systems-an-82255005.html 2026-09-02T00:43:34+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/pharmacokinetic-pk-considerations-for-centra-82743509.html 2026-09-02T00:48:24+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/pharmacokinetics-evaluation-of-antibody-drug-c-82743511.html 2026-09-02T00:48:23+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/progress-in-the-development-of-nucleic-acid-dr-82743514.html 2026-09-02T00:48:10+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/pharmacodynamics-evaluation-of-adcs-82743515.html 2026-09-02T00:48:25+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/prisys-biotech-establishes-cynomolgus-monkey-p-82743516.html 2026-09-02T00:48:36+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/comprehensive-non-human-primate-models-for-ren-82743518.html 2026-09-02T00:48:12+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/understanding-the-dmpk-of-adc-drugs-82743521.html 2026-09-02T00:48:14+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/comprehensive-preclinical-safety-evaluation-of-82743522.html 2026-09-02T00:48:01+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/2024-nobel-prize-in-physiology-or-medicine-82749917.html 2026-09-02T00:48:44+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/ocular-toxicity-studies-of-eye-drops-drug-exp-83040103.html 2026-09-02T00:49:12+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/real-time-intraoperative-mri-navigation-suppo-83040104.html 2026-09-02T00:48:52+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/drug-delivery-strategies-for-brain-diseases-83040108.html 2026-09-02T00:48:56+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/minipig-as-nonclinical-large-animal-84063043.html 2025-01-14T12:43:06+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/nasal-to-brain-n2b-drug-delivery-84063044.html 2026-09-02T00:52:09+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/nonclinical-drug-development-guide-toxicity-84063045.html 2025-01-14T12:43:03+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/prisys-annual-report-2024-advancing-nhp-model-84063046.html 2026-09-02T00:52:41+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/parkin-gene-deficiency-monkey-model-reveals-ne-84063047.html 2026-09-02T00:52:42+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/animal-models-for-atopic-dermatitis-84063048.html 2025-01-14T12:43:21+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/advancing-rheumatoid-arthritis-ra-research-w-84063060.html 2026-09-02T00:52:19+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/potential-routes-for-biologics-to-brain-84063067.html 2025-01-15T01:12:37+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/the-critical-role-of-animal-models-in-human-di-84082941.html 2025-02-28T10:54:44+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/meet-prisys-in-2025-us-roadshow-17248797184844800.html 2026-09-02T00:53:57+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/selecting-the-ideal-non-human-primate-for-toxi-17248797688357888.html 2026-09-02T00:52:18+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/systemic-lupus-erythematosus-sle-and-the-rol-17292804447216640.html 2026-07-26T00:46:13+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/animal-brain-stereotactic-instruments-17292804477576192.html 2025-03-31T02:13:59+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/non-human-primate-model-for-rheumatoid-arthrit-17292804540900352.html 2026-09-02T00:54:41+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/animal-models-challenges-and-applications-in-17292804587791360.html 2026-09-02T00:52:22+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/animal-models-for-womens-health-17292804763116544.html 2025-03-31T02:14:24+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-monkey-psoriasis-m-17292804797539328.html 2026-07-26T00:46:33+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/animal-models-for-in-vivo-testing-1-establi-17292804803109888.html 2026-07-26T00:46:44+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/membranous-nephropathy-model-17292804850541568.html 2025-03-31T02:14:20+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/integration-of-pharmacokinetics-and-pharmacody-17292804866024448.html 2026-09-02T00:53:02+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/what-does-proof-of-concept-poc-in-drug-devel-17292804874462208.html 2026-09-02T00:56:29+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/nonclinical-pharmacodynamic-research-17292804877509632.html 2026-09-02T00:52:27+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/microbial-testing-and-its-impact-on-nhp-17292804919092224.html 2026-09-02T00:52:25+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/pharmacokinetics-of-inhaled-drugs-17292805031093248.html 2026-09-10T15:41:28+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/world-obesity-day-nhp-metabolic-models-17292805041808384.html 2025-03-31T02:14:39+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/cynomolgus-monkey-endometriosis-model-17292805046150144.html 2026-07-26T00:46:41+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/nonclinical-immunotoxicity-assessment-strateg-17292805256848384.html 2026-07-26T00:49:33+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/targeting-interleukin-31-autoimmune-disease-17300292494992384.html 2026-07-26T00:47:02+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/advancing-parkinson-s-disease-research-with-th-17379910032548864.html 2026-07-26T00:47:07+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/intracerebral-icm-injection-precision-targe-17379910033662976.html 2026-09-02T00:53:06+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/intrathecal-it-injection-a-direct-cns-deliv-17379910126871552.html 2025-05-31T14:49:05+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/pharmacokinetics-pk-key-parameters-17379910185804800.html 2026-07-26T00:47:11+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/advanced-preclinical-inhalation-studies-techn-17379910297330688.html 2026-07-26T00:50:29+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/intracerebroventricular-icv-injection-17379910303310848.html 2026-07-26T00:51:05+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/preclinical-pk-pd-studies-nhp-models-17379910308635648.html 2026-09-02T00:52:35+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/aso-pharmacokinetics-absorption-17379910608102400.html 2026-07-26T00:47:17+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/nhp-inhalation-studies-for-biologics-prisys-17379910690202624.html 2026-09-02T00:55:19+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/asthma-research-why-non-human-primate-models-17379910765945856.html 2025-05-31T14:49:52+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/atopic-dermatitis-how-cynomolgus-monkey-model-17379910815736832.html 2026-07-26T00:47:10+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/designing-animal-studies-key-considerations-f-17379911126410240.html 2025-07-17T23:16:49+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/prisys-biotech-s-nhp-atopic-dermatitis-model-f-17446930191442944.html 2025-07-17T23:17:19+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/advancing-atopic-dermatitis-research-prisys-b-17446930374304768.html 2026-09-02T00:52:52+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/prisys-biotech-s-advanced-dsa-and-imri-for-hem-17446930498233344.html 2026-07-26T00:47:15+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/guiding-principles-for-animal-species-selectio-17446930515567616.html 2026-09-02T00:52:39+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/cynomolgus-monkey-pain-models-17446930577417216.html 2026-07-26T00:49:51+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/key-considerations-for-dosing-volume-17446930697462784.html 2026-07-26T00:47:26+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/a-guide-to-anti-drug-antibody-ada-assessment-17446930846311424.html 2026-09-02T00:53:30+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/respiratory-therapies-prisys-biotech-s-integr-17446930874770432.html 2025-07-17T23:16:45+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/nhp-model-platforms-to-support-drug-developmen-17446930969207808.html 2025-07-17T23:17:04+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/prisys-biotech-2025-mid-year-review-17446931415606272.html 2025-07-17T23:16:54+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/nhp-pain-models-accelerating-analgesic-drug-d-17446931534947328.html 2026-07-26T00:47:14+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/engineered-exosomes-revolutionizing-drug-deli-17446951388718080.html 2025-09-06T03:30:23+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/nhp-acute-hemorrhage-model-17517964244067328.html 2026-09-02T00:53:30+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/serum-vs-plasma-choosing-the-optimal-matrix-17517964436349952.html 2025-09-06T03:30:30+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/pruritus-research-il-31-nhp-itch-model-17517964451537920.html 2026-09-02T00:52:53+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/preclinical-dosing-guidelines-iv-po-volume-17517964454061056.html 2026-09-10T15:41:28+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/nhp-copd-model-17517979788305408.html 2026-09-10T15:41:28+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/nhp-pain-models-for-translational-drug-discove-17517979900224512.html 2025-09-15T07:08:52+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/brain-targeted-drug-delivery-17530929219232768.html 2026-07-26T00:49:47+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/adc-drug-development-translational-pk-pd-fra-17530929264534528.html 2025-09-15T07:08:40+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/the-importance-of-administration-volume-17530929269203968.html 2025-09-15T07:08:54+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/meet-prisys-biotech-at-upcoming-eu-roadshow-17530929423328256.html 2025-09-15T07:08:53+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/nhp-models-for-hematology-and-stroke-17530929427637248.html 2026-09-02T00:51:09+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/cynomolgus-monkey-biodistribution-study-17530929490600960.html 2025-09-15T07:08:57+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/idiopathic-pulmonary-fibrosis-ipf-nhp-model-17530929491878912.html 2026-09-02T00:53:40+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/cynomolgus-rhesus-monkey-models-prisys-bio-17537966385292288.html 2026-09-10T15:41:28+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/nhp-based-pharmacology-and-pharmacodynamic-17551243403895808.html 2026-09-02T00:53:05+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/shr-2004-a-breakthrough-in-vte-prevention-for-17658364360205312.html 2025-12-14T07:39:33+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/nasal-to-brain-n2b-delivery-technology-for-c-17658364525962240.html 2025-12-14T07:39:33+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/nhp-ai-based-behavioral-analysis-17658364547900416.html 2026-09-02T00:52:55+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/cold-allodynia-pain-model-in-cynomolgus-monkey-17658364700058624.html 2026-09-02T00:53:04+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/pk-study-targeted-drug-delivery-17658364740035584.html 2026-09-02T00:53:24+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/mri-guided-intracerebral-drug-delivery-17658364861342720.html 2025-12-14T07:39:54+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/rfp-template-for-nhp-studies-17658364867257344.html 2025-12-14T07:39:53+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/ai-based-nhp-behavioratlas-system-3d-behavi-17658364954289152.html 2026-07-26T00:50:58+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/th17-driven-nhp-immunology-models-17658364987663360.html 2026-07-26T00:43:22+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/nhp-renal-biopsy-17658365002327040.html 2025-12-14T07:39:55+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/nhp-respiratory-disease-models-and-airway-drug-17658365019743232.html 2026-07-26T00:47:46+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/cns-drug-candidates-in-preclinical-study-17671293707723776.html 2025-12-23T10:53:04+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/translational-car-t-evaluation-in-vitro-17671293737493504.html 2026-09-02T00:53:47+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/how-to-choose-a-reliable-preclinical-cro-key-17671293805863936.html 2026-07-26T00:47:37+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/parkinsons-disease-preclinical-models-17671293814318080.html 2025-12-23T10:53:05+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/high-precision-drug-delivery-and-ai-driven-nhp-17671293860881408.html 2025-12-23T10:53:24+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/one-to-multi-compartment-pk-models-17671293933331456.html 2025-12-23T10:53:14+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/ai-driven-markerless-3d-behavioral-analysis-17671293959578624.html 2025-12-23T10:53:14+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/hdm-seb-induced-atopic-dermatitis-atd-model-17671293981107200.html 2025-12-23T10:53:22+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/lps-induced-acute-lung-inflammation-ali-nhp-17671294337999872.html 2026-01-29T15:05:05+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/non-human-primate-mash-associated-liver-fibros-17723920550519808.html 2026-01-29T15:05:13+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/non-human-primate-models-are-critical-cns-17723920695206912.html 2026-01-29T15:05:17+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/imri-guided-brain-drug-delivery-17723920704611328.html 2026-01-29T15:05:12+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/multi-endpoint-pain-assessment-the-future-17723920736117760.html 2026-01-29T15:05:14+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/uric-acid-metabolism-in-humans-vs-monkeys-17723920744489984.html 2026-01-29T15:05:12+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/2025-recap-how-prisys-is-redefining-translati-17723920806896640.html 2026-01-29T15:05:23+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/emotional-memory-chronic-pain-nhp-models-17723920859931648.html 2026-01-29T15:05:14+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/analgesics-fail-in-preclinical-measure-pain-17723920862094336.html 2026-01-29T15:05:29+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/pk-statistical-analysis-nca-parameters-guide-17723920988791808.html 2026-01-29T15:06:21+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/blood-sampling-time-point-in-pharmacokinetic-17723921238500352.html 2026-05-09T04:31:04+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/translational-pk-pd-framework-cynomolgus-17864853116527616.html 2026-05-09T04:31:12+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/nhp-cns-biodistribution-studies-intrathecal-17864853793055744.html 2026-05-09T04:32:12+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/evaluating-dmpk-properties-17864854388696064.html 2026-05-09T04:32:05+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/mri-guided-cns-delivery-in-nhp-models-17864854393709568.html 2026-05-09T04:32:03+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/ai-markerless-nhp-3d-behavior-analysis-system-17864854412616704.html 2026-05-09T04:32:12+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/ipf-drug-development-nhp-ct-imaging-pft-17864854444844032.html 2026-09-10T15:41:28+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/drug-development-reliance-on-nhp-models-17864854786450432.html 2026-05-09T04:32:38+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/large-animal-radiolabeling-and-in-vivo-imaging-17864855300514816.html 2026-05-09T04:34:17+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/pet-ct-biodistribution-in-nhp-models-for-cns-17864856108033024.html 2026-05-09T04:35:41+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/nhp-av-shunt-thrombosis-model-antibody-safety-17864856962065408.html 2026-05-09T04:35:08+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/dopamine-transporter-pet-imaging-in-nhp-models-17864857085223936.html 2026-05-09T04:35:58+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/nonlinear-pharmacokinetics-nhp-pkpd-17864857176990720.html 2026-05-09T04:35:23+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/in-vivo-immune-cell-tracking-17864857819669504.html 2026-05-09T04:36:27+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/nonclinical-pharmacokinetics-strategy-17864857887351808.html 2026-05-09T04:36:08+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/prisys-supports-ind-approval-of-ux-gip001-17864857889383424.html 2026-05-09T04:36:19+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/non-glp-pharmacology-data-integrity-17864858096198656.html 2026-05-28T11:30:07+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/pk-data-as-pharmacodynamic-biomarker-17892159083914240.html 2026-05-28T11:29:05+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/non-human-primate-models-of-pulmonary-fibrosis-17892159099315200.html 2026-07-26T01:13:04+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/pk-data-as-translational-biomarker-17892159149663232.html 2026-05-28T11:28:22+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/nhp-models-translational-drug-development-17892159421391872.html 2026-07-26T01:12:51+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/on-demand-webinar-mri-ced-nhp-17892159822111744.html 2026-07-26T01:10:14+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/nhp-av-shunt-thrombosis-model-17936264015553536.html 2026-07-26T01:14:03+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/what-is-molecular-imaging-drug-development-17936264653399040.html 2026-07-26T01:12:58+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/nhp-heart-failure-model-17936264913953792.html 2026-07-26T01:12:56+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/dsa-cta-cardiovascular-drug-safety-imaging-17936265378538496.html 2026-07-26T01:14:04+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/nhp-molecular-imaging-translational-pet-studie-17936265497420800.html 2026-07-26T01:10:44+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/nonlinear-pharmacokinetics-explained-17936265713460224.html 2026-07-26T01:14:27+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/nhp-radionuclide-biodistribution-17936266014123008.html 2026-07-26T01:13:31+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/molecular-imaging-biomarkers-advancing-transl-17936266964952064.html 2026-07-26T00:43:03+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/clinical-pathology-interpretation-dogs-nhp-17936268066907136.html 2026-07-26T00:47:42+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/nhp-behavioratlas-3d-behavioral-tracking-17975046551462912.html 2026-07-26T00:47:34+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/nhp-models-of-maternal-high-fat-diet-and-child-17975046606283776.html 2026-09-10T15:41:28+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/ai-nhp-behavioral-analysis-17975053543203840.html 2026-07-26T00:52:32+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/pain-mechanisms-the-uvb-sunburn-model-17975053809574912.html 2026-07-26T21:56:56+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/baseline-ada-screening-washed-out-monkeys-17976295167517696.html 2026-07-26T21:57:00+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/nhp-aav-gene-therapy-model-mri-guided-ced-17976295217734656.html 2026-08-24T00:53:15+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/webinar-nhp-behavioratlas-17976295315088384.html 2026-07-26T21:58:12+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/why-positive-control-drugs-matter-in-autoimmun-17976295373857792.html 2026-07-26T21:57:10+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/markerless-3d-nhp-behavior-analysis-17976295956849664.html 2026-07-26T21:57:18+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/when-to-introduce-nhp-studies-autoimmune-drug-17976296969954304.html 2026-07-26T21:58:27+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/nhp-ibd-model-chronic-enterocolitis-17976297021514752.html 2026-08-02T14:22:03+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/midd-and-nhp-efficacy-models-in-drug-17985757426099200.html 2026-08-02T14:21:48+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/behavior-in-rhesus-17985757628228608.html 2026-08-05T15:35:05+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/pk-biomarkers-preclinical-drug-development-17990079036498944.html 2026-09-02T00:53:07+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/webinar-recap-digital-behavioral-phenotyping-17993013449909248.html 2026-09-02T00:53:21+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/molecular-imaging-in-nhp-model-webinar-18004422334194688.html 2026-09-02T00:53:07+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/pbpk-vs-compartmental-models-drug-development-18004423023715328.html 2026-09-02T00:53:28+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/3d-ai-tracking-nhp-behavior-18016109052208128.html 2026-08-24T02:53:33+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/pet-biodistribution-nhp-studies-18016218106979328.html 2026-09-02T00:54:44+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/quantitative-pet-target-engagement-in-nhps-for-18022027809530880.html 2026-09-01T11:32:07+08:00 weekly 0.8 https://otq.prisysbiotech.com/news/animal-models-succeed-or-fail-in-drug-dev-18028054721520640.html